To clarify, I wasn’t suggesting you were incapable of reading a primary reference (sorry if it read like that), just that posting a tonne of efficacy data here wasn’t the most appropriate forum for it (whilst acknowledging that you’d noted that no-one had posted any evidence).
I guess I was rationalizing why this was the case, and sharing a link to how the ACIP come to make evidence-based recommendations for the US. I think their system is pretty robust. The NHS/NICE do similar things but (obvs) have massive funding constraints that impinge on decisions that could otherwise be driven purely by clinical need.
Of course, reservations about applying US recommendations here is understandable. I hoped to explain why I thought their guidance was relevant.